207 related articles for article (PubMed ID: 31127985)
41. [Paralytic ileus as an initial manifestation of malignant VIPoma of the pancreas--case report with review of the literature].
Koberstein B; Eysselein VE; Balzer K; Müller MK; Eberlein G; Singer MV; Willemer S; Adler G; Goebell H
Z Gastroenterol; 1990 Jun; 28(6):295-301. PubMed ID: 1978446
[TBL] [Abstract][Full Text] [Related]
42. [Malignant vipoma of the head of the pancreas].
Wündrich B; Kunze KD; Dehne A
Zentralbl Chir; 1988; 113(3):199-203. PubMed ID: 2833842
[No Abstract] [Full Text] [Related]
43. Pancreatic vasoactive intestinal polypeptide-secreting tumor: report of a case.
Sheu HW; Chou SY; Yang KC; Kao CR; Yang TL; Shih CC
Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):931-5. PubMed ID: 2559939
[TBL] [Abstract][Full Text] [Related]
44. Preoperative localization of a vasoactive intestinal peptide-secreting tumor by transhepatic portal venous sampling.
Parkman HP; Malet PF; Ogorek CP; Burke DR; Deveney CW
Am J Gastroenterol; 1988 May; 83(5):559-63. PubMed ID: 2834945
[TBL] [Abstract][Full Text] [Related]
45. [VIPoma of the Pancreas].
Steck A; Nebiker C; Capraro J; Yurtsever H; Toutonji AA; Struja T
Praxis (Bern 1994); 2021 Sep; 110(11):637-642. PubMed ID: 34465193
[TBL] [Abstract][Full Text] [Related]
46. Medical therapy of VIPomas.
O'Dorisio TM; Mekhjian HS; Gaginella TS
Endocrinol Metab Clin North Am; 1989 Jun; 18(2):545-56. PubMed ID: 2545444
[TBL] [Abstract][Full Text] [Related]
47. Life-threating diarrhea and acute renal failure secondary to pancreatic VIPoma treated by surgery.
Lapeña Rodríguez M; Cholvi Calduch R; Muñoz Forner E; Garcés Albir M; Sabater Ortí L
Rev Esp Enferm Dig; 2019 Aug; 111(8):641-643. PubMed ID: 31232078
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
[TBL] [Abstract][Full Text] [Related]
50. Metastatic vipoma arising from colonic primary tumour.
Bradley C; Haddock G; Pickard RG; Rankin EM
Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
[TBL] [Abstract][Full Text] [Related]
51. Vasoactive Intestinal Peptide-Secreting Tumors: A Review.
Siddappa PK; Vege SS
Pancreas; 2019 Oct; 48(9):1119-1125. PubMed ID: 31609932
[TBL] [Abstract][Full Text] [Related]
52. Intractable and dramatic diarrhea in liver transplantation recipient with vasoactive intestinal peptide-producing tumor after split liver transplantation: a case report.
Haiqing W; Jiayin Y; Jian Y; Lunan Y
Transplant Proc; 2015; 47(1):171-3. PubMed ID: 25596962
[TBL] [Abstract][Full Text] [Related]
53. Percutaneous Irreversible Electroporation for Pancreatic VIPoma: A Case Report.
Niu L; Li J; Zeng J; Fang G; Zhou L; Xu K; Zhang K
Pancreas; 2017 Jan; 46(1):135-137. PubMed ID: 27977628
[TBL] [Abstract][Full Text] [Related]
54. Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.
Dahmani W; Nasr S; Maalel K; Becheikh Y; Tibaoui A; Lajmi Z; Hmissa S; Jaziri H; Elleuch N; Slama AB; Ameur WB; Ksiaa M; Jmaa A
Future Sci OA; 2023 Jan; 9(1):FSO836. PubMed ID: 37006228
[TBL] [Abstract][Full Text] [Related]
55. Massive amyloid deposition in pancreatic vipoma: a case report.
Crowley PF; Slavin JL; Rode J
Pathology; 1996 Nov; 28(4):377-9. PubMed ID: 9007963
[TBL] [Abstract][Full Text] [Related]
56. Watery diarrhea, hypokalemia and achlorhydria syndrome due to an adrenal pheochromocytoma.
Ikuta S; Yasui C; Kawanaka M; Aihara T; Yoshie H; Yanagi H; Mitsunobu M; Sugihara A; Yamanaka N
World J Gastroenterol; 2007 Sep; 13(34):4649-52. PubMed ID: 17729424
[TBL] [Abstract][Full Text] [Related]
57. Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.
Belei O; Basaca DG; Heredea ER; Iacob ER; Olariu L; Folescu R; Motoc AGM; Nanu AM; Mărginean O
Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895355
[TBL] [Abstract][Full Text] [Related]
58. Characterization of an alpha-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP).
Maltèse JY; Monge G; Giraud P; Salers P; Ouafik LH; Pelen F; Oliver C
Clin Endocrinol (Oxf); 1990 Oct; 33(4):467-80. PubMed ID: 2171816
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic VIPoma as a Differential Diagnosis in Chronic Pediatric Diarrhea: A Case Report and Review of the Literature.
Bonilla Gonzalez C; Rusinque J; Uribe C; Carias A; Contreras ML
J Med Cases; 2021 May; 12(5):195-201. PubMed ID: 34434457
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
